RESEARCH TRIANGLE PARK, NC--(Marketwire - December 9, 2010) - As many companies put the finishing touches on their 2011 Action Plans, the pharmaceutical and biotechnology sectors are looking to create opportunities from the challenges of recent years.
Cutting Edge Information, Inc. analyzed what issues its clients have studied most closely in 2010 and the resulting decisions and strategies they are likely to implement in 2011. "The popularity of each topic shows the areas that companies consider most important as they enter 2011," said Jason Richardson, president of Cutting Edge Information.
"These are the areas executives believe offer both challenges and opportunities that can provide competitive advantage if managed well in the next year."
The lists below include both the subject areas identified by industry executives and the top project conducted by Cutting Edge Information (http://www.cuttingedgeinfo.com/) for that functional group.
Top 3 Medical Affairs Reports
#1 Thought Leader Fair-Market Value: Compensation Benchmarks and Procedures
#2 Medical Science Liaison Programs -- The New MSL Profile: Internal Thought Leader, External Voice and Clinical Catalyst
#3 Pharmaceutical and Medical Device Regulatory Affairs
Top 3 Clinical Development Reports
#1 Benchmarking Drug Safety and Pharmacovigilance
#2 Streamlining Clinical Trials
#3 Clinical Trial Patient Recruitment
Top 3 Decision Support and Forecasting Reports
#1 Oncology Market Forecast to 2015
#2 Strategic Pharmaceutical Competitive Intelligence
#3 Diabetes Market Forecast to 2015
Top 3 Market Access Reports
#1 Health Economics and Outcomes Research
#2 Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform
#3 Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder Needs
Top 3 Portfolio Planning and Business Development Challenges
#1 Lifecycle Management: Strategy, Selection and Execution
#2 Pharmaceutical and Biotechnology Business Development: Accelerating the Deal
#3 Pharmaceutical Alliance Management
Top 3 Marketing and Commercialization Reports
#1 Countering Generics and Biosimilar Threats
#2 Pharmaceutical Speaker Programs
#3 Driving Successful Pharmaceutical Brands
Cutting Edge Information will continue to analyze key trends emerging from 2010 and impacting 2011 and beyond. More detail and background about Cutting Edge Information is available through the pharmaceutical Twitter feed, the life sciences research and consulting LinkedIn page, and a set of complimentary newsletters providing new management analysis monthly.
Contact Information:
For media inquiries, please contact
Stephanie Swanson
919-403-6583